#genomic data pipelines

Discover 2 curated intelligence briefings related to this specific topic.

Scaling In Vivo Therapy Erases the Manufacturing Bottleneck
Technology & Innovation

Scaling In Vivo Therapy Erases the Manufacturing Bottleneck

The shift toward in vivo CAR T and AAV gene therapies is fundamentally altering the economics of medicine. By eliminating the need to extract and modify cells outside the body, the industry is effectively pharmaceuticalizing gene therapy, though regulatory hurdles and clinical process inefficiencies still threaten the pace of adoption.

Read Analysis
Biological Markers Render the Forger Obsolete
Arts

Biological Markers Render the Forger Obsolete

As the art market faces a crisis of authenticity, elite galleries are secretly investing in DNA tagging and isotopic analysis to create an unbreakable link between a work of art and its creator.

Read Analysis